Described herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate drugs, this kind of programs like a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging wit